Moore D - Search Results

1

Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation.

Na B, Yu X, Withers T, Gilleran J, Yao M, Foo TK, Chen C, Moore D, Lin Y, Kimball SD, Xia B, Ganesan S, Carpizo DR. Na B, et al. Among authors: moore d. NPJ Breast Cancer. 2019 Apr 15;5:14. doi: 10.1038/s41523-019-0110-1. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 30993195 Free PMC article.

2

Survival following primary androgen deprivation therapy among men with localized prostate cancer.

Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Yao SL. Lu-Yao GL, et al. JAMA. 2008 Jul 9;300(2):173-81. doi: 10.1001/jama.300.2.173. JAMA. 2008. PMID: 18612114 Free PMC article.

3

Outcomes of localized prostate cancer following conservative management.

Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O'Leary M, Walker-Corkery E, Yao SL. Lu-Yao GL, et al. JAMA. 2009 Sep 16;302(11):1202-9. doi: 10.1001/jama.2009.1348. JAMA. 2009. PMID: 19755699 Free PMC article.

4

Deficiency of the dual ubiquitin/SUMO ligase Topors results in genetic instability and an increased rate of malignancy in mice.

Marshall H, Bhaumik M, Aviv H, Moore D, Yao M, Dutta J, Rahim H, Gounder M, Ganesan S, Saleem A, Rubin E. Marshall H, et al. Among authors: moore d. BMC Mol Biol. 2010 Apr 29;11:31. doi: 10.1186/1471-2199-11-31. BMC Mol Biol. 2010. PMID: 20429939 Free PMC article.

5

Late gastrointestinal toxicities following radiation therapy for prostate cancer.

Kim S, Shen S, Moore DF, Shih W, Lin Y, Li H, Dolan M, Shao YH, Lu-Yao GL. Kim S, et al. Eur Urol. 2011 Nov;60(5):908-16. doi: 10.1016/j.eururo.2011.05.052. Epub 2011 Jun 12. Eur Urol. 2011. PMID: 21684064 Free PMC article.

6

On calculating the probability of a set of orthologous sequences.

Liu J, Chen L, Zhao H, Moore DF, Lin Y, Shih WJ. Liu J, et al. Adv Appl Bioinform Chem. 2009;2:37-48. doi: 10.2147/aabc.s4616. Epub 2009 Feb 26. Adv Appl Bioinform Chem. 2009. PMID: 21918614 Free PMC article.

7

Low p53 binding protein 1 (53BP1) expression is associated with increased local recurrence in breast cancer patients treated with breast-conserving surgery and radiotherapy.

Neboori HJ, Haffty BG, Wu H, Yang Q, Aly A, Goyal S, Schiff D, Moran MS, Golhar R, Chen C, Moore D, Ganesan S. Neboori HJ, et al. Among authors: moore d. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e677-83. doi: 10.1016/j.ijrobp.2012.01.089. Epub 2012 Apr 18. Int J Radiat Oncol Biol Phys. 2012. PMID: 22520477

8

Does primary androgen-deprivation therapy delay the receipt of secondary cancer therapy for localized prostate cancer?

Lu-Yao GL, Albertsen PC, Li H, Moore DF, Shih W, Lin Y, DiPaola RS, Yao SL. Lu-Yao GL, et al. Eur Urol. 2012 Dec;62(6):966-72. doi: 10.1016/j.eururo.2012.05.003. Epub 2012 May 10. Eur Urol. 2012. PMID: 22608160 Free PMC article.

9

Severe genitourinary toxicity following radiation therapy for prostate cancer--how long does it last?

Kim S, Moore DF, Shih W, Lin Y, Li H, Shao YH, Shen S, Lu-Yao GL. Kim S, et al. J Urol. 2013 Jan;189(1):116-21. doi: 10.1016/j.juro.2012.08.091. Epub 2012 Nov 16. J Urol. 2013. PMID: 23164376 Free PMC article.

10

Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications.

Shao YH, Moore DF, Shih W, Lin Y, Jang TL, Lu-Yao GL. Shao YH, et al. BJU Int. 2013 May;111(5):745-52. doi: 10.1111/j.1464-410X.2012.11758.x. Epub 2013 Jan 17. BJU Int. 2013. PMID: 23331464 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,112 results

Search Page

Filters